Anzeige
Mehr »
Login
Dienstag, 23.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
35 Leser
Artikel bewerten:
(0)

Research and Markets - Nuclear Imaging Equipment Market to Reach $2.85 Billion by 2021, with CMR Naviscan Corporation, DDD-Diagnostic, Digirad Corporation & GE Healthcare Dominating

DUBLIN, Jan 19, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Nuclear Imaging Equipment Market - Global Forecasts to 2021" report to their offering.

The nuclear imaging equipment market is projected to reach USD 2.85 Billion by 2021 from USD 2.25 Billion in 2016, growing at a CAGR of 4.8% during the forecast period, owing to factors such as introduction of new and advanced products, investment for the modernization of diagnostic imaging centers, development of new radio-tracers, and increasing incidence of cancer & cardiovascular diseases are expected to drive the growth of the market.

The global market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is further divided into SPECT systems, Hybrid PET and Planar Scintigraphy. The SPECT systems segment is expected to command the largest share whereas the Hybrid PET systems are expected to grow at the highest CAGR during the forecast period.

On the basis of application, the market has been segmented into oncology, cardiology, neurology and other applications (orthopedics, urology, thyroid-related disorders, and gastroenterology). The oncology segment is expected to command the largest share of the global market by applications. However, cardiac applications hold the majority share in case of SPECT applications and oncology applications hold the largest share in case of PET applications.

On the basis of end user, the nuclear imaging market is segmented into hospitals, imaging centers, academic & research centers, and other end users (pharmaceutical & biotechnology companies and CROs). In 2016, the hospitals segment is expected to account for the largest share and grow at the highest CAGR during the forecast period.

Companies Mentioned:

  • CMR Naviscan Corporation
  • DDD-Diagnostic A/S
  • Digirad Corporation
  • GE Healthcare
  • Mediso Medical Imaging Systems Ltd.
  • Neusoft Medical Systems Co., Ltd.
  • Philips Healthcare
  • Siemens AG (Siemens Healthineers)
  • Surgiceye GmbH
  • Toshiba Medical Systems Corporation

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Nuclear Imaging Equipment Market, By Product

8 Nuclear Imaging Equipment Market, By Application

9 Nuclear Imaging Equipment Market, By End User

10 Nuclear Imaging Equipment Market, By Region

11 Competitive Landscape

12 Company Profiles

13 Appendix

For more information about this report visit http://www.researchandmarkets.com/research/l324mf/nuclear_imaging

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.